121765 AG 825 - CAS 149092-50-2 - Calbiochem

121765
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical FormulaCAS #
C₁₉H₁₅N₃O₃S₂ 149092-50-2

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
121765-2MGCN
在庫状況検索中…
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 2 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER2 (neu/ErbB2; IC50 = 0.35 µM) relative to HER1 (IC50 = 19 µM) autophosphorylation. The inhibition is competitive with respect to ATP binding. Enhances chemosensitivity in non-small cell lung cancer (NSCLC) cell lines expressing high levels of p185neu.
      Catalogue Number121765
      Brand Family Calbiochem®
      Synonyms4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidenecyanoacetamide
      References
      ReferencesAshton, J.M., et al. 2012. Cell Stem Cell 11, 359.
      Tsai, C.M., et al. 1996. Cancer Res. 56, 1068.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134.
      Product Information
      CAS number149092-50-2
      ATP CompetitiveN
      FormYellow solid
      Hill FormulaC₁₉H₁₅N₃O₃S₂
      Chemical formulaC₁₉H₁₅N₃O₃S₂
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetHER2
      Primary Target IC<sub>50</sub>0.35 µM against HER2
      Purity≥94% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2-3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      AG 825 - CAS 149092-50-2 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      AG 825 - CAS 149092-50-2 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      121765

      参考資料

      参考資料の概要
      Ashton, J.M., et al. 2012. Cell Stem Cell 11, 359.
      Tsai, C.M., et al. 1996. Cancer Res. 56, 1068.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision24-March-2015 JSW
      Synonyms4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidenecyanoacetamide
      DescriptionA potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER-2 (neu/erbB-2, IC50 = 0.35 µM) relative to HER-1 (IC50 = 19 µM) autophosphorylation. The inhibition is competitive with respect to ATP binding. Enhances the chemosensitivity in non-small cell lung cancer (NSCLC) cell lines expressing high levels of p185neu.
      FormYellow solid
      CAS number149092-50-2
      Chemical formulaC₁₉H₁₅N₃O₃S₂
      Structure formulaStructure formula
      Purity≥94% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage -20°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2-3 months at -20°C.
      Toxicity Standard Handling
      ReferencesAshton, J.M., et al. 2012. Cell Stem Cell 11, 359.
      Tsai, C.M., et al. 1996. Cancer Res. 56, 1068.
      Levitzki, A., and Gazit, A. 1995. Science 267, 1782.
      Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134.